Menu

USDA Removes Animal Welfare Data From Public Website

Due to privacy concerns, the US Department of Agriculture will no longer make animal welfare inspection reports and enforcement records public.

Feb 7, 2017
Joshua A. Krisch

WIKIMEDIA, APHIS

Update (February 14): Yesterday, People for the Ethical Treatment of Animals (PETA), the Physicians Committee for Responsible Medicine, and others jointly filed a lawsuit against the USDA, arguing that the agency violated the Freedom of Information Act. The complaint asks the judge to order USDA to reinstate electronic access to all the records.

“The government should not be in the business of hiding animal abusers and lawbreakers from public scrutiny,” Delcianna Winders, a co-plaintiff and Academic Fellow of the Harvard Animal Law & Policy Program, said in a statement sent to ScienceInsider.

The US Department of Agriculture (USDA)’s decision to remove all animal welfare data from its website has sparked controversy among animal activists, Nature reported. The USDA’s Animal and Plant Health Inspection Service announced the decision on Friday (February 3), citing the agency’s “commitment to being transparent, remaining responsive to our stakeholders’ informational needs, and maintaining the privacy rights of individuals.”

Animal welfare groups were quick to retort. “Claiming ‘privacy’ is a smokescreen to unjustifably evade critical transparency about government operations,” Justin Goodman of the animal advocacy group White Coat Waste Project told Nature.

On Monday (February 6), activists at the Humane Society of the United States criticized the move and promised to challenge it. “This outrageous action undermines longstanding consensus about public access to information concerning these laws, and frustrates state, local, and industry efforts to help enforce them,” Humane Society Chief Executive Officer Wayne Pacelle said in a statement sent to reporters.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.